Associations of cigarette smoking, e-cigarette use, and dual use with newly diagnosed arthritis: a longitudinal cohort analysis
Year: 2026
Type: article
Abstract: INTRODUCTION: Cigarette smoking is an established risk factor for rheumatoid arthritis, but longitudinal evidence on e-cigarette use, dual use, and broader arthritis outcomes remains limited. We examined whether baseline cigarette and e-cigarette use status was associated with newly diagnosed arthritis reported at follow-up. METHODS: We analysed data from the UK Household Longitudinal Study (UKHLS) among participants who did not report a previous arthritis diagnosis at Wave 10 (2018-2019; baseline). Baseline cigarette and e-cigarette use was classified into four mutually exclusive groups: neither current cigarette nor e-cigarette use, exclusive current cigarette use, exclusive current e-cigarette use, and dual use. The outcome was newly diagnosed arthritis reported at Wave 14 (2022-2023; follow-up). Modified Poisson regression with robust standard errors was used to estimate risk ratios (RRs) and 95% confidence intervals. Adjusted models included age modelled using a four-knot restricted cubic spline, sex, ethnicity, rural-urban residence, and highest educational qualification. Sensitivity analyses additionally adjusted for alcohol use and fruit and vegetable intake measured at Wave 9, excluded participants who reported arthritis at Waves 11-13, and applied stricter e-cigarette-use definitions. RESULTS: Among 18,802 participants included in the primary analysis, 587 (3.12%) reported newly diagnosed arthritis at Wave 14. The unadjusted proportions were 3.05% among participants reporting neither current cigarette nor e-cigarette use, 3.83% among exclusive cigarette users, 2.21% among exclusive e-cigarette users, and 4.47% among dual users (overall p = 0.064). Compared with participants reporting neither current cigarette nor e-cigarette use, exclusive cigarette use was associated with a higher adjusted risk of newly diagnosed arthritis (RR 1.43, 95% CI 1.11-1.84; p = 0.005), as was dual use (RR 1.79, 95% CI 1.10-2.90; p = 0.019). Exclusive e-cigarette use was not associated with newly diagnosed arthritis (RR 1.01, 95% CI 0.61-1.68; p = 0.965). Compared with the primary analysis, estimates were similar after additional adjustment for alcohol use and fruit and vegetable intake (exclusive cigarette use: RR 1.39, 95% CI 1.06-1.82; p = 0.017; dual use RR 1.79, 95% CI 1.09-2.94; p = 0.022) and after excluding participants who reported arthritis at Waves 11-13 (exclusive cigarette use: RR 1.50, 95% CI 1.09-2.06; p = 0.012; dual use: RR 1.92, 95% CI 1.03-3.57; p = 0.040). When e-cigarette use was restricted to at least monthly or weekly use, the association for exclusive cigarette use remained stable, exclusive e-cigarette use showed no evidence of an association, and the dual-use estimates were attenuated and less precise. CONCLUSIONS: Exclusive cigarette smoking and dual cigarette-e-cigarette use were associated with a higher risk of newly diagnosed arthritis in the primary analysis. No association was identified for exclusive e-cigarette use, although precision was limited. Studies with clinically verified arthritis outcomes, repeated exposure assessment, and stronger control of cumulative smoking and adiposity are needed. Key Points • Exclusive cigarette use was associated with a 43% higher adjusted risk of newly diagnosed arthritis. • Dual cigarette and e-cigarette use was associated with a 79% higher adjusted risk in the primary analysis. • Exclusive e-cigarette use was not associated with newly diagnosed arthritis, but the estimate was imprecise. • Dual-use estimates weakened when e-cigarette use was restricted to at least monthly or weekly use.
Source: Clinical Rheumatology
Authors: Yusuff Adebayo Adebisi(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing), Anas Ali Alhur(Conceptualization, Investigation, Methodology, Writing – review & editing), Isaac Olushola Ogunkola(Investigation, Methodology, Writing – review & editing), Henry Eziefule Nwankwo(Investigation, Writing – review & editing), Maleek Olanrewaju Olatunji(Investigation, Writing – review & editing), Don Eliseo Lucero-Prisno
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,890
OpenAlex ID: W7236768260
